366789-02-8 Rivaroxaban 98%

Srini Pharmaceuticals Pvt. Ltd., was established in 1995.  USFDA, TGA and KFDA approved fully integrated global pharmaceutical company, located just about 60 KM's away from the Pharma Capital of India, Hyderabad.

Our manufacturing facility has five fully equipped production blocks with most efficient functional utilities with multiple clean rooms having the ability to produce 10 API's at a time, supported by central quality control laborites with all sophisticated instruments by maintaining complete QMS.

The state-of-the-Art Research and development laboratory recognized and approved by Department of Science and Technology, Government of India.

Dr. T.C. Reddy is the Managing Director of the Company.  He is a Doctorate in Chemical Engineering with close to 3 decades of experience in different segments of the Pharma Industry ranging from the invention /improvement of molecules to marketing of the Bulk Drugs, Drug Intermediates and Formulations both in India and Abroad.

He worked extensively across multiple and leading fortune 500 companies in the U.S.A., putting to practice his technical skills and expertise, coupled with smart business acumen in manufacturing and marketing of API's and intermediates.  This unique combination of technological expertise and sharp business skills has enabled him transform many organizations in the past and continuous to maintain the same level of efficiency, productivity and consistency at SRINI.